Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool

Elizabeth D. Hermsen, Patrick M. McDaneld, Edward H. Eiland, Christopher J. Destache, Katherine Lusardi, Sandy J. Estrada, Renée Claude Mercier, Daryl D. DePestel, Kenneth C. Lamp, Evette Anderson, Thomas J. Chung, Peggy S. McKinnon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided.

Original languageEnglish
Pages (from-to)S179-S184
JournalClinical Infectious Diseases
Volume59
DOIs
StatePublished - Oct 15 2014

Fingerprint

Industry
Drug Industry
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Breaking down the barriers : challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool. / Hermsen, Elizabeth D.; McDaneld, Patrick M.; Eiland, Edward H.; Destache, Christopher J.; Lusardi, Katherine; Estrada, Sandy J.; Mercier, Renée Claude; DePestel, Daryl D.; Lamp, Kenneth C.; Anderson, Evette; Chung, Thomas J.; McKinnon, Peggy S.

In: Clinical Infectious Diseases, Vol. 59, 15.10.2014, p. S179-S184.

Research output: Contribution to journalArticle

Hermsen, ED, McDaneld, PM, Eiland, EH, Destache, CJ, Lusardi, K, Estrada, SJ, Mercier, RC, DePestel, DD, Lamp, KC, Anderson, E, Chung, TJ & McKinnon, PS 2014, 'Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool', Clinical Infectious Diseases, vol. 59, pp. S179-S184. https://doi.org/10.1093/cid/ciu539
Hermsen, Elizabeth D. ; McDaneld, Patrick M. ; Eiland, Edward H. ; Destache, Christopher J. ; Lusardi, Katherine ; Estrada, Sandy J. ; Mercier, Renée Claude ; DePestel, Daryl D. ; Lamp, Kenneth C. ; Anderson, Evette ; Chung, Thomas J. ; McKinnon, Peggy S. / Breaking down the barriers : challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool. In: Clinical Infectious Diseases. 2014 ; Vol. 59. pp. S179-S184.
@article{735d3671e2924d77b5b1e61dc5dd6d69,
title = "Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool",
abstract = "Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided.",
author = "Hermsen, {Elizabeth D.} and McDaneld, {Patrick M.} and Eiland, {Edward H.} and Destache, {Christopher J.} and Katherine Lusardi and Estrada, {Sandy J.} and Mercier, {Ren{\'e}e Claude} and DePestel, {Daryl D.} and Lamp, {Kenneth C.} and Evette Anderson and Chung, {Thomas J.} and McKinnon, {Peggy S.}",
year = "2014",
month = "10",
day = "15",
doi = "10.1093/cid/ciu539",
language = "English",
volume = "59",
pages = "S179--S184",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Breaking down the barriers

T2 - challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool

AU - Hermsen, Elizabeth D.

AU - McDaneld, Patrick M.

AU - Eiland, Edward H.

AU - Destache, Christopher J.

AU - Lusardi, Katherine

AU - Estrada, Sandy J.

AU - Mercier, Renée Claude

AU - DePestel, Daryl D.

AU - Lamp, Kenneth C.

AU - Anderson, Evette

AU - Chung, Thomas J.

AU - McKinnon, Peggy S.

PY - 2014/10/15

Y1 - 2014/10/15

N2 - Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided.

AB - Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided.

UR - http://www.scopus.com/inward/record.url?scp=84925883267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925883267&partnerID=8YFLogxK

U2 - 10.1093/cid/ciu539

DO - 10.1093/cid/ciu539

M3 - Article

C2 - 25261545

AN - SCOPUS:84925883267

VL - 59

SP - S179-S184

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -